Structurebased sitespecific pegylation of fibroblast growth factor 2 facilitates rational selection of conjugate sites
At-home stack: roughly $700 to $1,200 in devices plus $200 to $300 per year in consumables
Having targeted Hims & Hers last year, the FDA has issued warnings to more telehealth companies over their promotion of GLP-1 drugs used to treat diabetes and obesity
During the COVID-19 pandemic, drug manufacturers struggled to keep up with demand
A responsible provider should: Complete prior authorizations when required by insurancepromptly and accuratelyto avoid delays or denials Identify patient assistance programs offered by manufacturers, especially for low-income or uninsured individuals Help patients apply for financial assistance when eligible, rather than leaving them to navigate the paperwork alone Compare pharmacy pricing and use tools or services to find the most cost-effective fulfillment options Clarify insurance-specific nuances , including formulary differences, co-pay tiers, and requirements for step therapy or appeals Cost transparency and patient advocacy are essential parts of quality diabetes and weight management care, especially when medications can be life-changing
